Search research articles
Contact Us
Filters
Showing results (21-30 of 83) with videos related to
Page
of 9
Sort By:
The Biochemical Journal
|
July 7, 1999
The mechanism of activation of NADPH oxidase in the cell-free system: the activation process is primarily catalytic and not through the formation of a stoichiometric complex
A R Cross, R W Erickson, J T Curnutte
The Biochemical Journal
|
November 1, 1986
The development of cytochrome b-245 in maturing human macrophages
R C Garcia, A R Cross, A W Segal
American Journal of Veterinary Research
|
June 1, 1997
Kinetic gait analysis assessment of meloxicam efficacy in a sodium urate-induced synovitis model in dogs
A R Cross, S C Budsberg, T J Keefe
Blood
|
September 25, 1999
Functional analysis of NADPH oxidase in granulocytic cells expressing a delta488-497 gp91(phox) deletion mutant
L Yu, A R Cross, L Zhen, et al.
Human Genetics
|
August 21, 2001
A second case of somatic triple mosaicism in the CYBB gene causing chronic granulomatous disease
D Noack, P G Heyworth, W Kyono, et al.
Biochemical and Biophysical Research Communications
|
May 18, 2000
NADH-ferric reductase activity associated with dihydropteridine reductase
P L Lee, C Halloran, A R Cross, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 8, 1998
Gp91(phox) is the heme binding subunit of the superoxide-generating NADPH oxidase
L Yu, M T Quinn, A R Cross, et al.
The Biochemical Journal
|
December 15, 1982
The association of FAD with the cytochrome b-245 of human neutrophils
A R Cross, O T Jones, R Garcia, et al.
Blood Cells, Molecules & Diseases
|
January 1, 1996
Hematologically important mutations: X-linked chronic granulomatous disease
A R Cross, J T Curnutte, J Rae, et al.
Biochimica Et Biophysica Acta
|
September 22, 2001
An unusual intronic mutation in the CYBB gene giving rise to chronic granulomatous disease
D Noack, P G Heyworth, P E Newburger, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 83) with videos related to
Sort By:
Page
of 9
The Biochemical Journal
|
July 7, 1999
The mechanism of activation of NADPH oxidase in the cell-free system: the activation process is primarily catalytic and not through the formation of a stoichiometric complex
A R Cross, R W Erickson, J T Curnutte
The Biochemical Journal
|
November 1, 1986
The development of cytochrome b-245 in maturing human macrophages
R C Garcia, A R Cross, A W Segal
American Journal of Veterinary Research
|
June 1, 1997
Kinetic gait analysis assessment of meloxicam efficacy in a sodium urate-induced synovitis model in dogs
A R Cross, S C Budsberg, T J Keefe
Blood
|
September 25, 1999
Functional analysis of NADPH oxidase in granulocytic cells expressing a delta488-497 gp91(phox) deletion mutant
L Yu, A R Cross, L Zhen, et al.
Human Genetics
|
August 21, 2001
A second case of somatic triple mosaicism in the CYBB gene causing chronic granulomatous disease
D Noack, P G Heyworth, W Kyono, et al.
Biochemical and Biophysical Research Communications
|
May 18, 2000
NADH-ferric reductase activity associated with dihydropteridine reductase
P L Lee, C Halloran, A R Cross, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 8, 1998
Gp91(phox) is the heme binding subunit of the superoxide-generating NADPH oxidase
L Yu, M T Quinn, A R Cross, et al.
The Biochemical Journal
|
December 15, 1982
The association of FAD with the cytochrome b-245 of human neutrophils
A R Cross, O T Jones, R Garcia, et al.
Blood Cells, Molecules & Diseases
|
January 1, 1996
Hematologically important mutations: X-linked chronic granulomatous disease
A R Cross, J T Curnutte, J Rae, et al.
Biochimica Et Biophysica Acta
|
September 22, 2001
An unusual intronic mutation in the CYBB gene giving rise to chronic granulomatous disease
D Noack, P G Heyworth, P E Newburger, et al.
Page
of 9